Word

PASMAX

Status

Dead

Status Code

710

Status Date

Friday, May 5, 2023

Serial Number

86919081

Registration Number

5067522

Registration Date

Tuesday, October 25, 2016

Mark Type

5000

Filing Date

Thursday, February 25, 2016

Published for Opposition

Tuesday, August 9, 2016

Cancellation Date

Friday, May 5, 2023

Trademark Owner History

celares GmbH - Original Registrant

Classifications

5 Chemical reagents for medical or veterinary purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Cytostatics for pharmaceutical purposes; Drug delivery agents in the form of molecular solubility enhancer that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine

1 Active chemical ingredients and solvents for use in the manufacture of insecticides; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Chemicals for use in biotechnological product development; Chemicals for use in biotechnological manufacturing processes

42 Chemical laboratories; Chemical research; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Pharmaceutical drug development services; Research and development in the pharmaceutical and biotechnology fields; Research in the field of Antibody drug conjugates

The mark consists of the letters "P a S m a x" with the letters "max" being superscript. The mark is black and white.
PAS MAX
Color is not claimed as a feature of the mark.

Trademark Events

May 5, 2023

Cancelled Sec. 8 (6-Yr)

Oct 25, 2021

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Oct 25, 2016

Registered-Principal Register

Aug 9, 2016

Official Gazette Publication Confirmation E-Mailed

Aug 9, 2016

Published For Opposition

Jul 20, 2016

Notification Of Notice Of Publication E-Mailed

Jul 2, 2016

Law Office Publication Review Completed

Jun 27, 2016

Approved For Pub - Principal Register

Jun 25, 2016

Teas/Email Correspondence Entered

Jun 25, 2016

Correspondence Received In Law Office

Jun 22, 2016

Teas Response To Office Action Received

Jun 21, 2016

Notification Of Non-Final Action E-Mailed

Jun 21, 2016

Non-Final Action E-Mailed

Jun 21, 2016

Non-Final Action Written

Jun 20, 2016

Teas/Email Correspondence Entered

Jun 20, 2016

Correspondence Received In Law Office

Jun 20, 2016

Assigned To Lie

Jun 13, 2016

Teas Response To Office Action Received

Jun 10, 2016

Notification Of Non-Final Action E-Mailed

Jun 10, 2016

Non-Final Action E-Mailed

Jun 10, 2016

Non-Final Action Written

Jun 10, 2016

Assigned To Examiner

Mar 1, 2016

Notice Of Pseudo Mark E-Mailed

Feb 29, 2016

New Application Office Supplied Data Entered

Feb 29, 2016

New Application Entered